miQURE

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark miQURE was filed as Word mark on 04/09/2019 at the World Intellectual Property Organization.

Trademark Details Last update: June 22, 2021

Trademark form Word mark
File reference 1480032
Countries Australia Japan
Base trademark EU No. 017979806, November 2, 2018
Application date April 9, 2019
Expiration date April 9, 2029

Trademark owner

Paasheuvelweg 25
1105 BP Amsterdam
NL

Trademark representatives

Rembrandt Tower, 28th Floor Amstelplein 1 NL

goods and services

05 Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy
42 Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; research and product development in the field of pharmaceutical
44 Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; pharmaceutical consultancy

Trademark history

Date Document number Area Entry
June 10, 2021 2021/24 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
November 24, 2020 2020/49 Gaz AU RAW: Rule 18ter(2)(i) GP following a provisional refusal
August 27, 2020 2020/35 Gaz JP Rejection
November 20, 2019 2020/2 Gaz AU Rejection
April 9, 2019 2019/29 Gaz EM Registration

ID: 141480032